Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: An integrated analysis of the complete database of multicenter placebo-controlled trials

Persistence of attention deficit hyperactivity disorder (ADHD) into adulthood can be disabling or lead to substantial impairment. Several clinical trials of atomoxetine (ATX) in adults with ADHD have been reported following the National Institute for Health and Clinical Excellence (NICE) guidelines...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Psychopharmacol
Hlavní autoři: Asherson, Philip, Bushe, Chris, Saylor, Keith, Tanaka, Yoko, Deberdt, Walter, Upadhyaya, Himanshu
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2014
Témata:
Original Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4230847/
https://ncbi.nlm.nih.gov/pubmed/25035246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0269881114542453
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky